3,796 research outputs found

    The effect of offset on fracture permeability of rocks from the Southern Andes Volcanic Zone, Chile

    Get PDF
    The Southern Andes Volcanic Zone (SVZ) represents one of the largest undeveloped geothermal provinces in the world. Development of the geothermal potential requires a detailed understanding of fluid transport properties of its main lithologies. The permeability of SVZ rocks is altered by the presence of fracture damage zones produced by the Liquiñe-Ofqui Fault System (LOFS) and the Andean Transverse Faults (ATF). We have therefore measured the permeability of four representative lithologies from the volcanic basement in this area: crystalline tuff, andesitic dike, altered andesite and granodiorite. For comparative purposes, we have also measured the permeability of samples of Seljadalur basalt, an Icelandic rock with widely studied and reported hydraulic properties. Specifically, we present the results of a systematic study of the effect of fractures and fracture offsets on permeability as a function of increasing effective pressure. Baseline measurements on intact samples of SVZ rocks show that the granodiorite has a permeability (10−18 m2), two orders of magnitude higher than that of the volcanic rocks (10−20 m2). The presence of throughgoing mated macro-fractures increases permeability by between four and six orders of magnitude, with the highest permeability recorded for the crystalline tuff. Increasing fracture offset to produce unmated fractures results in large increases in permeability up to some characteristic value of offset, beyond which permeability changes only marginally. The increase in permeability with offset appears to depend on fracture roughness and aperture, and these are different for each lithology. Overall, fractured SVZ rocks with finite offsets record permeability values consistent with those commonly found in geothermal reservoirs (>10−16 m2), which potentially allow convective/advective flow to develop. Hence, our results demonstrate that the fracture damage zones developed within the SVZ produce permeable regions, especially within the transtensional NE-striking fault zones, that have major importance for geothermal energy resource potential

    Exoplanet phase curves: observations and theory

    Full text link
    Phase curves are the best technique to probe the three dimensional structure of exoplanets' atmospheres. In this chapter we first review current exoplanets phase curve observations and the particular challenges they face. We then describe the different physical mechanisms shaping the atmospheric phase curves of highly irradiated tidally locked exoplanets. Finally, we discuss the potential for future missions to further advance our understanding of these new worlds.Comment: Fig.5 has been updated. Table 1 and corresponding figures have been updated with new values for WASP-103b and WASP-18b. Contains a table sumarizing phase curve observation

    The cord blood insulin and mitochondrial DNA content related methylome

    Get PDF
    Mitochondrial dysfunction seems to play a key role in the etiology of insulin resistance. At birth, a link has already been established between mitochondrial DNA (mtDNA) content and insulin levels in cord blood. In this study, we explore shared epigenetic mechanisms of the association between mtDNA content and insulin levels, supporting the developmental origins of this link. First, the association between cord blood insulin and mtDNA content in 882 newborns of the ENVIRONAGE birth cohort was assessed. Cord blood mtDNA content was established via qPCR, while cord blood levels of insulin were determined using electrochemiluminescence immunoassays. Then the cord blood DNA methylome and transcriptome were determined in 179 newborns, using the human 450K methylation Illumina and Agilent Whole Human Genome 8 × 60 K microarrays, respectively. Subsequently, we performed an epigenome-wide association study (EWAS) adjusted for different maternal and neonatal variables. Afterward, we focused on the 20 strongest associations based on p-values to assign transcriptomic correlates and allocate corresponding pathways employing the R packages ReactomePA and RDAVIDWebService. On the regional level, we examined differential methylation using the DMRcate and Bumphunter packages in R. Cord blood mtDNA content and insulin were significantly correlated (r = 0.074, p = 0.028), still showing a trend after additional adjustment for maternal and neonatal variables (p = 0.062). We found an overlap of 33 pathways which were in common between the association with cord blood mtDNA content and insulin levels, including pathways of neurodevelopment, histone modification, cytochromes P450 (CYP)-metabolism, and biological aging. We further identified a DMR annotated to Repulsive Guidance Molecule BMP Co-Receptor A (RGMA) linked to cord blood insulin as well as mtDNA content. Metabolic variation in early life represented by neonatal insulin levels and mtDNA content might reflect or accommodate alterations in neurodevelopment, histone modification, CYP-metabolism, and aging, indicating etiological origins in epigenetic programming. Variation in metabolic hormones at birth, reflected by molecular changes, might via these alterations predispose children to metabolic diseases later in life. The results of this study may provide important markers for following targeted studies

    Vitamin D supplementation and breast cancer prevention : a systematic review and meta-analysis of randomized clinical trials

    Get PDF
    In recent years, the scientific evidence linking vitamin D status or supplementation to breast cancer has grown notably. To investigate the role of vitamin D supplementation on breast cancer incidence, we conducted a systematic review and meta-analysis of randomized controlled trials comparing vitamin D with placebo or no treatment. We used OVID to search MEDLINE (R), EMBASE and CENTRAL until April 2012. We screened the reference lists of included studies and used the “Related Article” feature in PubMed to identify additional articles. No language restrictions were applied. Two reviewers independently extracted data on methodological quality, participants, intervention, comparison and outcomes. Risk Ratios and 95% Confident Intervals for breast cancer were pooled using a random-effects model. Heterogeneity was assessed using the I2 test. In sensitivity analysis, we assessed the impact of vitamin D dosage and mode of administration on treatment effects. Only two randomized controlled trials fulfilled the pre-set inclusion criteria. The pooled analysis included 5372 postmenopausal women. Overall, Risk Ratios and 95% Confident Intervals were 1.11 and 0.74–1.68. We found no evidence of heterogeneity. Neither vitamin D dosage nor mode of administration significantly affected breast cancer risk. However, treatment efficacy was somewhat greater when vitamin D was administered at the highest dosage and in combination with calcium (Risk Ratio 0.58, 95% Confident Interval 0.23–1.47 and Risk Ratio 0.93, 95% Confident Interval 0.54–1.60, respectively). In conclusions, vitamin D use seems not to be associated with a reduced risk of breast cancer development in postmenopausal women. However, the available evidence is still limited and inadequate to draw firm conclusions. Study protocol code: FARM8L2B5L

    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

    Get PDF
    Background Many patients with type 2 diabetes do not achieve sustained diabetes remission after metabolic (bariatric) surgery for the treatment of obesity. Liraglutide, a glucagon-like peptide-1 analogue, improves glycaemic control and reduces bodyweight in patients with type 2 diabetes. Our aim was to assess the safety and efficacy of liraglutide 1·8 mg in patients with persistent or recurrent type 2 diabetes after metabolic surgery. Methods In the GRAVITAS randomised double-blind, placebo-controlled trial, we enrolled adults who had undergone Roux-en-Y gastric bypass or vertical sleeve gastrectomy and had persistent or recurrent type 2 diabetes with HbA1c levels higher than 48 mmol/mol (6·5%) at least 1 year after surgery from five hospitals in London, UK. Participants were randomly assigned (2:1) via a computer-generated sequence to either subcutaneous liraglutide 1·8 mg once daily or placebo, both given together with a reduced-calorie diet, aiming for a 500 kcal per day deficit from baseline energy intake, and increased physical activity. The primary outcome was the change in HbA1c from baseline to the end of the study period at 26 weeks, assessed in patients who completed the trial. Safety was assessed in the safety analysis population, consisting of all participants who received either liraglutide or placebo. This trial is registered with EudraCT, number 2014-003923-23, and the ISRCTN registry, number ISRCTN13643081. Findings Between Jan 29, 2016, and May 2, 2018, we assigned 80 patients to receive either liraglutide (n=53) or placebo (n=27). 71 (89%) participants completed the study and were included in the principal complete-cases analysis. In a multivariable linear regression analysis, with baseline HbA1c levels and surgery type as covariates, liraglutide treatment was associated with a difference of −13·3 mmol/mol (−1·22%, 95% CI −19·7 to −7·0; p=0·0001) in HbA1c change from baseline to 26 weeks, compared with placebo. Type of surgery had no significant effect on the outcome. 24 (45%) of 53 patients assigned to liraglutide and 11 (41%) of 27 assigned to placebo reported adverse effects: these were mainly gastrointestinal and in line with previous experience with liraglutide. There was one death during the study in a patient assigned to the placebo group, which was considered unrelated to study treatment. Interpretation These findings support the use of adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery

    Energetic nuclear transients in luminous and ultraluminous infrared galaxies

    Get PDF
    Energetic nuclear outbursts have been discovered in luminous and ultraluminous infrared galaxies (U/LIRGs) at unexpectedly high rates. To investigate this population of transients, we performed a search in mid-IR data from the Wide-field Infrared Survey Explorer (WISE) satellite and its NEOWISE survey to detect and characterise luminous and smoothly evolving transients in a sample of 215 U/LIRGs. We report three new transients, all with ΔL >  1043 erg s−1, in addition to two previously known cases. Their host galaxies are all part of major galaxy mergers, and through radiative transfer model fitting we find that all have a significant contribution from an active galactic nucleus (AGN). We characterised the transients through measurements of their luminosities and resulting energetics, all of which are between 1050.9 erg and 1052.2 erg. The IR emission of the five transients was found to be consistent with re-radiation by the hot dust of emission at shorter wavelengths, presumably originating from an accretion event, onto the supermassive black hole. The corresponding transient rate of (1.6–4.6) × 10−3 yr−1 galaxy−1 is over an order of magnitude higher than the rate of large amplitude flares shown by AGN in the optical. We suggest that the observed transients are part of a dust-obscured population of tidal disruption events (TDEs) that have remained out of the reach of optical surveys due to the obscuring dust. In one case, this is supported by our radio observations. We also discuss other plausible explanations. The observed rate of events is significantly higher than optical TDE rates, which can be expected in U/LIRG hosts undergoing a major galaxy merger with increased stellar densities in the nuclear regions. Continued searches for such transients and their multi-wavelength follow-up is required to constrain their rate and nature. </p

    Mapping gene associations in human mitochondria using clinical disease phenotypes

    Get PDF
    Nuclear genes encode most mitochondrial proteins, and their mutations cause diverse and debilitating clinical disorders. To date, 1,200 of these mitochondrial genes have been recorded, while no standardized catalog exists of the associated clinical phenotypes. Such a catalog would be useful to develop methods to analyze human phenotypic data, to determine genotype-phenotype relations among many genes and diseases, and to support the clinical diagnosis of mitochondrial disorders. Here we establish a clinical phenotype catalog of 174 mitochondrial disease genes and study associations of diseases and genes. Phenotypic features such as clinical signs and symptoms were manually annotated from full-text medical articles and classified based on the hierarchical MeSH ontology. This classification of phenotypic features of each gene allowed for the comparison of diseases between different genes. In turn, we were then able to measure the phenotypic associations of disease genes for which we calculated a quantitative value that is based on their shared phenotypic features. The results showed that genes sharing more similar phenotypes have a stronger tendency for functional interactions, proving the usefulness of phenotype similarity values in disease gene network analysis. We then constructed a functional network of mitochondrial genes and discovered a higher connectivity for non-disease than for disease genes, and a tendency of disease genes to interact with each other. Utilizing these differences, we propose 168 candidate genes that resemble the characteristic interaction patterns of mitochondrial disease genes. Through their network associations, the candidates are further prioritized for the study of specific disorders such as optic neuropathies and Parkinson disease. Most mitochondrial disease phenotypes involve several clinical categories including neurologic, metabolic, and gastrointestinal disorders, which might indicate the effects of gene defects within the mitochondrial system. The accompanying knowledgebase (http://www.mitophenome.org/) supports the study of clinical diseases and associated genes
    corecore